Transseptal mitral valve‐in‐valve implantation in a degenerated mitral bioprosthesis: A case report and literature review
Abstract Transseptal TMViV should be considered for mitral bioprosthesis failure especially when large THV can be implanted. Elevated residual mean gradient and its effect on valve durability and potential valve thrombosis remains an unanswered question.
Main Authors: | Nils Perrin, Hajo Müller, Stephane Noble |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-06-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.4251 |
Similar Items
-
Emergency transapical mitral valve-in-valve implantation for bioprosthesis failure: transapical implantation of an Edwards Sapien-XT in a dysfunctional mitral bioprosthesis in a critical patient
by: Marco Zanobini, et al.
Published: (2017-12-01) -
Transseptal transcatheter mitral valve replacement
by: V. I. Ganyukov, et al.
Published: (2020-09-01) -
Outcomes following transcatheter transseptal versus transapical mitral valve-in-valve and valve-in-ring procedures
by: Salik Nazir, et al.
Published: (2018-12-01) -
EARLY DEGENERATED BIOPROSTHETIC MITRAL VALVE
by: Irina-Mihaela Ciomaga, et al.
Published: (2014-09-01) -
Transcatheter mitral valve-in-valve implantation for failed bioprosthesis
by: Tahir I Mohamed, et al.
Published: (2020-12-01)